Hyperuricemia Impaired Nitric Oxide Bioavailability and Deteriorated Pulmonary Arterial Hypertension in Xanthine Oxidoreductase (XOR)-Independent Manner in Rats

MLA

T. Ohtsubo, et al. “Hyperuricemia Impaired Nitric Oxide Bioavailability and Deteriorated Pulmonary Arterial Hypertension in Xanthine Oxidoreductase (XOR)-Independent Manner in Rats.” D108. WHAT IS HOT, WHAT IS NEW? EMERGING MOLECULAR TARGETS IN PULMONARY HYPERTENSION AND ACUTE LUNG INJURY, May 2020. EBSCOhost, https://doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a7843.

APA

T. Ohtsubo, Satomi Imakiire, K Abe, Tomohito Ishikawa, Kiyoko Kaneko, M. Ishikawa, Tomoko Fukuuchi, Takanori Watanabe, & Hiroyuki Tsutsui. (2020). Hyperuricemia Impaired Nitric Oxide Bioavailability and Deteriorated Pulmonary Arterial Hypertension in Xanthine Oxidoreductase (XOR)-Independent Manner in Rats. D108. WHAT IS HOT, WHAT IS NEW? EMERGING MOLECULAR TARGETS IN PULMONARY HYPERTENSION AND ACUTE LUNG INJURY. https://doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a7843

Chicago

T. Ohtsubo, Satomi Imakiire, K Abe, Tomohito Ishikawa, Kiyoko Kaneko, M. Ishikawa, Tomoko Fukuuchi, Takanori Watanabe, and Hiroyuki Tsutsui. 2020. “Hyperuricemia Impaired Nitric Oxide Bioavailability and Deteriorated Pulmonary Arterial Hypertension in Xanthine Oxidoreductase (XOR)-Independent Manner in Rats.” D108. WHAT IS HOT, WHAT IS NEW? EMERGING MOLECULAR TARGETS IN PULMONARY HYPERTENSION AND ACUTE LUNG INJURY, May. doi:10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a7843.